EP3154536

XPO1 ANTAGONIST KPT-251 FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    9.6.2015
  • EP published:
    1.11.2023
  • EP application number:
    15731531.8
  • Max expiry date:
    8.6.2035
  • Title in English:
    XPO1 ANTAGONIST KPT-251 FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME
  • Language of the patent:
    English

Timeline

Today
9.6.2015EP application
1.11.2023EP Publication

Owner

  • Name:
    Institut National de la Santé et de la Recherche Médicale (INSERM)
  • Address:
    101, rue de Tolbiac, 75013 Paris, FR
  • Name:
    Fondation Imagine
  • Address:
    24, Boulevard du Montparnasse, 75015 Paris, FR
  • Name:
    Assistance Publique-Hôpitaux de Paris (APHP)
  • Address:
    3, avenue Victoria, 75004 Paris, FR
  • Name:
    Université Paris Cité
  • Address:
    85 boulevard Saint-Germain, 75006 Paris, FR
  • Name:
    Centre National de la Recherche Scientifique (C.N.R.S.)
  • Address:
    3, rue Michel-Ange, 75016 Paris, FR

Inventor

  • Name:
    HERMINE, Olivier
  • Address:
    75015 Paris, FR
  • Name:
    ARLET, Jean-Benoit
  • Address:
    75015 Paris, FR
  • Name:
    GUILLEM, Flavia
  • Address:
    75015 Paris, FR
  • Name:
    COURTOIS, Genevève
  • Address:
    75015 Paris, FR
  • Name:
    FONTENAY, Michaela
  • Address:
    75014 Paris, FR

Priority

  • Number:
    14305873
  • Date:
    10.6.2014
  • Country:
    EP

Classification

  • Categories:
    A61K 31/422, A61P 35/02

Upload documents